These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
3. Identification of candidate single-nucleotide polymorphisms in NRXN1 related to antipsychotic treatment response in patients with schizophrenia. Jenkins A; Apud JA; Zhang F; Decot H; Weinberger DR; Law AJ Neuropsychopharmacology; 2014 Aug; 39(9):2170-8. PubMed ID: 24633560 [TBL] [Abstract][Full Text] [Related]
4. Association study between the neurexin-1 gene and tardive dyskinesia. Lanning R; Lett TA; Tiwari AK; Brandl EJ; de Luca V; Voineskos AN; Potkin SG; Lieberman JA; Meltzer HY; Müller DJ; Remington G; Kennedy JL; Zai CC Hum Psychopharmacol; 2017 Jan; 32(1):. PubMed ID: 28120489 [TBL] [Abstract][Full Text] [Related]
5. Neurexin-1 and frontal lobe white matter: an overlapping intermediate phenotype for schizophrenia and autism spectrum disorders. Voineskos AN; Lett TA; Lerch JP; Tiwari AK; Ameis SH; Rajji TK; Müller DJ; Mulsant BH; Kennedy JL PLoS One; 2011; 6(6):e20982. PubMed ID: 21687627 [TBL] [Abstract][Full Text] [Related]
6. A case-control association study of NRXN1 polymorphisms with schizophrenia in Chinese Han population. Yue W; Yang Y; Zhang Y; Lu T; Hu X; Wang L; Ruan Y; Lv L; Zhang D Behav Brain Funct; 2011 Apr; 7():7. PubMed ID: 21477380 [TBL] [Abstract][Full Text] [Related]
7. Outcome definitions and clinical predictors influence pharmacogenetic associations between HTR3A gene polymorphisms and response to clozapine in patients with schizophrenia. Rajkumar AP; Poonkuzhali B; Kuruvilla A; Srivastava A; Jacob M; Jacob KS Psychopharmacology (Berl); 2012 Dec; 224(3):441-9. PubMed ID: 22700043 [TBL] [Abstract][Full Text] [Related]
8. The role of the ITIH3 rs2535629 variant in antipsychotic response. Brandl EJ; Lett TA; Chowdhury NI; Tiwari AK; Bakanidze G; Meltzer HY; Potkin SG; Lieberman JA; Kennedy JL; Müller DJ Schizophr Res; 2016 Oct; 176(2-3):131-135. PubMed ID: 27396837 [TBL] [Abstract][Full Text] [Related]
9. Schizophrenia severity and clozapine treatment outcome association with oxytocinergic genes. Souza RP; de Luca V; Meltzer HY; Lieberman JA; Kennedy JL Int J Neuropsychopharmacol; 2010 Jul; 13(6):793-8. PubMed ID: 20196918 [TBL] [Abstract][Full Text] [Related]
10. Genetic association analysis of N-methyl-D-aspartate receptor subunit gene GRIN2B and clinical response to clozapine. Taylor DL; Tiwari AK; Lieberman JA; Potkin SG; Meltzer HY; Knight J; Remington G; Müller DJ; Kennedy JL Hum Psychopharmacol; 2016 Mar; 31(2):121-34. PubMed ID: 26876050 [TBL] [Abstract][Full Text] [Related]
11. Selected single-nucleotide variants in GRIN1, GRIN2A, and GRIN2B encoding subunits of the NMDA receptor are not biomarkers of schizophrenia resistant to clozapine: exploratory study. Krzystanek M; Asman M; Witecka J; Pałasz A; Wiaderkiewicz R Pharmacol Rep; 2021 Feb; 73(1):309-315. PubMed ID: 33025395 [TBL] [Abstract][Full Text] [Related]
12. Preliminary evidence for association of genome-wide significant DRD2 schizophrenia risk variant with clozapine response. Huang E; Maciukiewicz M; Zai CC; Tiwari AK; Li J; Potkin SG; Lieberman JA; Meltzer HY; Müller DJ; Kennedy JL Pharmacogenomics; 2016; 17(2):103-9. PubMed ID: 26666695 [TBL] [Abstract][Full Text] [Related]
13. COMT val108/158met genotype, cognitive function, and cognitive improvement with clozapine in schizophrenia. Woodward ND; Jayathilake K; Meltzer HY Schizophr Res; 2007 Feb; 90(1-3):86-96. PubMed ID: 17123785 [TBL] [Abstract][Full Text] [Related]
14. Serotonin subtype 2 receptor genes and clinical response to clozapine in schizophrenia patients. Masellis M; Basile V; Meltzer HY; Lieberman JA; Sevy S; Macciardi FM; Cola P; Howard A; Badri F; Nöthen MM; Kalow W; Kennedy JL Neuropsychopharmacology; 1998 Aug; 19(2):123-32. PubMed ID: 9629566 [TBL] [Abstract][Full Text] [Related]
15. Association analysis for NMDA receptor subunit 2B (GRIN2B) genetic variants and psychopathology and clozapine response in schizophrenia. Hong CJ; Yu YW; Lin CH; Cheng CY; Tsai SJ Psychiatr Genet; 2001 Dec; 11(4):219-22. PubMed ID: 11807413 [TBL] [Abstract][Full Text] [Related]
16. Dopamine D4 receptor gene exon III polymorphism and interindividual variation in response to clozapine. Zhao AL; Zhao JP; Zhang YH; Xue ZM; Chen JD; Chen XG Int J Neurosci; 2005 Nov; 115(11):1539-47. PubMed ID: 16223700 [TBL] [Abstract][Full Text] [Related]
17. Pharacogenetic effects of dopamine transporter gene polymorphisms on response to chlorpromazine and clozapine and on extrapyramidal syndrome in schizophrenia. Xu M; Xing Q; Li S; Zheng Y; Wu S; Gao R; Yu L; Guo T; Yang Y; Liu J; Zhang A; Zhao X; He G; Zhou J; Wang L; Xuan J; Du J; Li X; Feng G; Lin Z; Xu Y; St Clair D; Lin Z; He L Prog Neuropsychopharmacol Biol Psychiatry; 2010 Aug; 34(6):1026-32. PubMed ID: 20580759 [TBL] [Abstract][Full Text] [Related]
18. Association study of 12 polymorphisms spanning the dopamine D(2) receptor gene and clozapine treatment response in two treatment refractory/intolerant populations. Hwang R; Shinkai T; De Luca V; Müller DJ; Ni X; Macciardi F; Potkin S; Lieberman JA; Meltzer HY; Kennedy JL Psychopharmacology (Berl); 2005 Aug; 181(1):179-87. PubMed ID: 15830237 [TBL] [Abstract][Full Text] [Related]
19. Family and case-control association study of the tumor necrosis factor-alpha (TNF-alpha) gene with schizophrenia and response to antipsychotic medication. Zai G; Müller DJ; Volavka J; Czobor P; Lieberman JA; Meltzer HY; Kennedy JL Psychopharmacology (Berl); 2006 Oct; 188(2):171-82. PubMed ID: 16932925 [TBL] [Abstract][Full Text] [Related]
20. Lack of association between DRD3 gene polymorphism and response to clozapine in Turkish schizoprenia patients. Barlas IO; Cetin M; Erdal ME; Semiz UB; Basoglu C; Ay ME; Herken H; Uzun O Am J Med Genet B Neuropsychiatr Genet; 2009 Jan; 150B(1):56-60. PubMed ID: 18449897 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]